Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 24, 2003New England Journal of Medicine

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMichel AttalUniversité de Tours
Thierry Façon
Thierry FaçonRoswell Park Comprehensive Cancer Center
FGFrançois GuilhotInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Attal et al. (2003) studied this question.

synapsesocial.com/papers/6a7d31e7da72e8de9c279232https://doi.org/10.1056/nejmoa032290
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma2003 · 1,774 citations
  2. 2Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.1998 · 438 citations
  3. 3Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial2002 · 568 citations
  4. 4Double-intensive therapy in high-risk multiple myeloma1992 · 97 citations
  5. 5Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study2003 · 163 citations